Auvi-Q Offers Free Epinephrine Auto-Injectors to Elementary Schools

2162
By:
in Food Allergy, News
Published: August 22, 2017

A new program, offering free epinephrine auto-injectors to all public elementary schools across the United States, has launched to improve access to the life-saving medication in a school setting.

Kaléo, the company behind the Auvi-Q epinephrine auto-injector, says their new ‘Q Your School’ program will provide up to eight epinephrine auto-injectors and four trainers per school in an academic year. The pharmaceutical company will also give each school educational material on how to identify symptoms of a severe allergic reaction and respond in an emergency.

There are approximately 67,000 public elementary schools across the U.S., and company cites that nearly six million children under the age of 18 live with life-threatening allergies.

“We are proud to offer the ‘Q Your School’ charitable donation program offering free Auvi-Q auto-injectors to all public elementary schools across the nation,” Spencer Williamson, president and CEO of Kaléo, said in a press release. The compact Auvi-Q auto-injector is known for its how-to-inject voice instructions.

Kaléo says there are no obligations, such as marketing or product exclusivity requirements attached to the program. Schools can apply for ‘Q Your School’ here and any questions can be sent via email to donationrequest@kaleopharma.com.

Mylan, which distributes the EpiPen, offers a similar initiative called EpiPen4Schools for schools in states where stock epinephrine is allowed. In that program, public elementary, middle and high schools are eligible to receive free of charge up to four EpiPen or EpiPen Jr auto-injectors in a year. They also receive free EpiPen trainers, free replacement of the product if the free supply gets used, a symptoms of anaphylaxis poster, a storage unit for the auto-injectors and a training video. See more on the EpiPen4Schools program here.

Related: Auto-Injector Choices for 2017: Auvi-Q Returns, Generics Available Across U.S.